# HeartLight Guided - Pure Pulmonary Vein Isolation Regardless of Concomitant Atrial Substrate

Study · id `cardio:ct-nct02655731` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02655731](<https://clinicaltrials.gov/study/NCT02655731>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02655731

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT02655731. Allocation not applicable; no masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2018-03-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT02655731, source copy `cardio:ctgov-nct02655731-2019-08-13`, retrieved 2026-10-26)
- Start date: 2015-12 (registry gives no type) (ClinicalTrials.gov record NCT02655731, source copy `cardio:ctgov-nct02655731-2019-08-13`, retrieved 2026-10-26)
- Primary completion: 2018-03-20 (actual) (ClinicalTrials.gov record NCT02655731, source copy `cardio:ctgov-nct02655731-2019-08-13`, retrieved 2026-10-26)
- Completion: 2018-03-20 (actual) (ClinicalTrials.gov record NCT02655731, source copy `cardio:ctgov-nct02655731-2019-08-13`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT02655731, source copy `cardio:ctgov-nct02655731-2019-08-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02655731-2019-08-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: HeartLight Guided - Pure Pulmonary Vein Isolation Regardless of Concomitant Atrial Substrate
- Acronym: HEURECA
- Condition: Atrial Fibrillation
- Intervention (Device): PVI with HeartLight
- Lead sponsor: Cardioangiologisches Centrum Bethanien
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 200e033431bd1f30cfa7dd904d6df7e1b4ecdb52256abfd72e322831ceba8774
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
